Cart
sales@molnova.com
LHW090-A7
CAS No. 1308256-94-1
LHW090-A7( —— )
Catalog No. M22031 CAS No. 1308256-94-1
LHW090-A7 is an neutral endopeptidase (NEP) inhibitor, and an enzyme responsible for the metabolic inactivation of enkephalins.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 45 | In Stock |
|
| 5MG | 74 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLHW090-A7
-
NoteResearch use only, not for human use.
-
Brief DescriptionLHW090-A7 is an neutral endopeptidase (NEP) inhibitor, and an enzyme responsible for the metabolic inactivation of enkephalins.
-
DescriptionLHW090-A7 is an neutral endopeptidase (NEP) inhibitor, and an enzyme responsible for the metabolic inactivation of enkephalins.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetNeprilysin
-
Recptorneutral endopeptidase (NEP)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1308256-94-1
-
Formula Weight375.8
-
Molecular FormulaC20H22ClNO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCOC(=O)[C@H](C)N[C@@H](CC1=CC=C(C=C1)C1=CC(Cl)=CC=C1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PL265
PL265 (PL-265) is a dual enkephalinase inhibitor, alleviate corneal pain and inflammation in vivo.
-
LCZ-696
A novel single molecule comprising molecular moieties of valsartan and NEP inhibitor prodrug AHU377.
-
Candoxatrilat
A potent neutral endopeptidase EC 3.4.24.11 (atriopeptidase) inhibitor.
